Dambkowski Carl 4

What Happened

• Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics (APGE), reported exercising options to acquire 4,125 shares at $22.86 per share (cash paid ≈ $94,298) on March 4, 2026. On the same day he sold a total of 5,500 shares in open‑market transactions for aggregate proceeds of approximately $390,825.
• The filing also shows a related derivative disposition of 4,125 shares at $0.00 (reported as a derivative conversion/settlement in connection with the exercise). The transactions were executed under a Rule 10b5‑1 trading plan.

Key Details

• Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (no late‑filing flag shown).
• Exercise (acquired): 4,125 shares @ $22.86 = $94,298.
• Derivative disposition: 4,125 shares @ $0.00 (reported as a derivative conversion/settlement).
• Open‑market sales (total disposed = 5,500 shares, proceeds ≈ $390,825):
  • 3,225 shares, weighted avg $70.33 (prices ranged $70.30–$70.82).
  • 2,075 shares, weighted avg $71.98 (prices ranged $71.51–$72.45).
  • 200 shares, weighted avg $73.26 (prices ranged $73.20–$73.31).
• Shares owned after the transactions: not specified in the materials provided here (check the full Form 4 for post‑transaction holdings).
• Notable footnotes:
  • F1: Sales executed pursuant to a Rule 10b5‑1 trading plan adopted Sept 22, 2025 (pre‑planned trades).
  • F2–F4: Reported sale prices are weighted averages across multiple transactions; exact per‑trade breakdowns available on request per the footnotes.
  • F5: The option underlying these exercises is part of a larger grant (right to purchase 175,345 shares vesting monthly through Dec 18, 2027).

Context

• This was an option exercise combined with immediate open‑market sales. Because the sales were executed under a 10b5‑1 plan, they are generally considered pre‑arranged and routine rather than ad‑hoc insider selling.
• For retail investors: purchases (or unambiguous net buys) are often more indicative of bullish insider sentiment than planned sales. Here, the net economic effect is that shares were acquired via option exercise while a larger number of shares were sold under a pre‑arranged plan.